Greystone Financial Group LLC Purchases Shares of 17,462 UnitedHealth Group Incorporated (NYSE:UNH)

Greystone Financial Group LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 17,462 shares of the healthcare conglomerate's stock, valued at approximately $9,146,000. UnitedHealth Group makes up about 1.7% of Greystone Financial Group LLC's holdings, making the stock its 28th largest holding.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Courier Capital LLC lifted its stake in UnitedHealth Group by 3.0% in the first quarter. Courier Capital LLC now owns 4,320 shares of the healthcare conglomerate's stock worth $2,263,000 after purchasing an additional 127 shares during the last quarter. Wesbanco Bank Inc. lifted its stake in shares of UnitedHealth Group by 0.7% in the 1st quarter. Wesbanco Bank Inc. now owns 52,206 shares of the healthcare conglomerate's stock valued at $27,343,000 after acquiring an additional 338 shares during the last quarter. First Citizens Bank & Trust Co. grew its position in UnitedHealth Group by 5.0% during the 1st quarter. First Citizens Bank & Trust Co. now owns 40,443 shares of the healthcare conglomerate's stock worth $21,182,000 after acquiring an additional 1,923 shares during the last quarter. Tilia Fiduciary Partners Inc. lifted its position in UnitedHealth Group by 4.4% in the first quarter. Tilia Fiduciary Partners Inc. now owns 3,953 shares of the healthcare conglomerate's stock valued at $2,070,000 after purchasing an additional 167 shares during the last quarter. Finally, BCS Wealth Management grew its holdings in shares of UnitedHealth Group by 42.6% in the first quarter. BCS Wealth Management now owns 1,623 shares of the healthcare conglomerate's stock worth $850,000 after purchasing an additional 485 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on UNH shares. Deutsche Bank Aktiengesellschaft dropped their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Oppenheimer cut their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their target price for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $428.43.

UnitedHealth Group Price Performance

Shares of UNH opened at $303.24 on Monday. The firm's 50-day simple moving average is $409.03 and its two-hundred day simple moving average is $482.60. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The stock has a market cap of $275.08 billion, a PE ratio of 19.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the firm posted $6.91 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the firm's stock in a transaction on Friday, May 16th. The stock was acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.